Literature DB >> 15153829

Emergency and early carotid endarterectomy in patients with acute ischemic stroke selected with a predefined protocol. A prospective pilot study.

E Sbarigia1, D Toni, F Speziale, A Falcou, M L Sacchetti, M A Panico, M Fiorelli, C Argentino, E Ducasse, P Fiorani.   

Abstract

AIM: The appropriateness of early carotid endarterectomy (CEA) in patients with acute ischemic stroke is still unsettled. The aim of this study was to verify the safety and feasibility of early CEA in a consecutive series of patients with acute ischemic stroke observed in an emergency Department Stroke Unit.
METHODS: During a 24-month study, out of 756 patients with acute ischemic stroke 33 (4.4%) were scheduled for early CEA. Endarterectomy procedures were distinguished according to the time between the onset of stroke and operation as emergency (within 8 hours), early CEA (1-18 days). Patients with impaired consciousness or an infarct larger than 2.5 cm on computed tomographic (CT) or magnetic resonance (MR) scans or both were excluded from surgery. All patients underwent spiral CT, echo-color-Doppler (ECD) sonography, transcranial Doppler (TCD) sonography and, when necessary, MR angiography within 6 hours of admission. No patient underwent conventional angiography. Most patients were operated on under cervical block (CB) anesthesia; general anesthesia (GA) was used only for those with an unstable neurological deficit. Selective shunting was used on the basis of intra-operative transcranial Doppler in patients under GA and the onset or worsening of neurological deficit under CB anesthesia.
RESULTS: Of the 6 patients operated on within a median 6 hours after the onset of stroke, 1 (16.5%) had a fatal hemorrhagic transformation of the infarct, while the remaining 5 (83.5%) stopped fluctuating or progressing and had a favourable neurological outcome. Of the 16 patients operated on within a median 36 hours and of the 11 patients operated on within 7 days, none deteriorated after operation.
CONCLUSION: Emergency CEA is feasible for acute ischaemic stroke provided that strict selection criteria are applied and the door-to-surgery interval is kept short (within 8 hours). Early CEA for secondary prevention is feasible and safe, confirming that a delayed operation is in most cases unwarranted. Large randomized trials are warranted before implementing emergent and early CEA in routine clinical practice.

Entities:  

Mesh:

Year:  2003        PMID: 15153829

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  5 in total

1.  Endovascular recanalization of internal carotid artery occlusion in acute ischemic stroke.

Authors:  Rebecca M Sugg; Marc D Malkoff; Elizabeth A Noser; Hashem M Shaltoni; Raymond Weir; Edwin D Cacayorin; James C Grotta
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

2.  [Indication for emergent revascularisation of acute carotid occlusion].

Authors:  B T Weis-Müller; R Huber; A Spivak-Dats; B Turowski; R Seitz; M Siebler; W Sandmann
Journal:  Chirurg       Date:  2007-11       Impact factor: 0.955

3.  Anterior Circulation Acute Ischemic Stroke Associated with Atherosclerotic Lesions of the Cervical ICA: A Nosologic Entity Apart.

Authors:  O F Eker; P Panni; C Dargazanli; G Marnat; C Arquizan; P Machi; I Mourand; G Gascou; E Le Bars; V Costalat; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-19       Impact factor: 3.825

Review 4.  Immediate versus delayed treatment for recently symptomatic carotid artery stenosis.

Authors:  Vladimir Vasconcelos; Nicolle Cassola; Edina Mk da Silva; Jose Cc Baptista-Silva
Journal:  Cochrane Database Syst Rev       Date:  2016-09-09

5.  Emergency Carotid Endarterectomy Instead of Carotid Artery Stenting Reduces Delayed Hemorrhage in Thrombectomy Stroke Patients.

Authors:  Raveena Singh; Sven Dekeyzer; Arno Reich; Drosos Kotelis; Alexander Gombert; Martin Wiesmann; Omid Nikoubashman
Journal:  Clin Neuroradiol       Date:  2020-09-17       Impact factor: 3.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.